Compare
Intelligent Bio Solutions Inc. vs Tenon Medical, Inc. vs IceCure Medical Ltd. vs OSR Health, Inc.
| Latest fiscal year | Intelligent Bio Solutions Inc. INBS | Tenon Medical, Inc. TNON | IceCure Medical Ltd. ICCM | OSR Health, Inc. OSRH |
|---|---|---|---|---|
| Year ended | 2026-06-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $4.22M | $3.94M | $3.38M | $2.91M |
| Revenue growth (YoY) | +38.1% | +20.4% | +2.7% | -17.7% |
| Gross margin | 48.6% | 59.8% | 36.3% | 20.4% |
| Operating margin | -299.1% | -324.3% | -446.7% | -631.0% |
| Net margin | -294.9% | -318.4% | -445.6% | -931.2% |
| Net income | -$12.43M | -$12.56M | -$15.06M | -$27.06M |
| EPS (Diluted) | -$8.44 | -$1.70 | $0.24 | -$0.80 |
| Operating cash flow | -$11.93M | -$10.74M | -$14.57M | -$4.33M |
| Free cash flow | -$12.05M | -$11.02M | -$14.61M | n/a |
| Cash & equivalents | $3.99M | $3.76M | $8.90M | $1.70M |
| Total assets | $11.94M | $10.76M | $13.89M | $171.24M |
| Total liabilities | $6.65M | $5.72M | n/a | $44.20M |
| Shareholders' equity | $5.51M | $5.04M | $9.05M | $127.04M |
| Return on year-end equity | -225.6% | -249.1% | -166.4% | -21.3% |
| Shares outstanding | 2.91M | 10.85M | 73.12M | 26.60M |
Revenue, most recent five fiscal years
| Fiscal year | Intelligent Bio Solutions Inc. | Tenon Medical, Inc. | IceCure Medical Ltd. | OSR Health, Inc. |
|---|---|---|---|---|
| Latest | $4.22M Ended 2026-06-30 | $3.94M Ended 2025-12-31 | $3.38M Ended 2025-12-31 | $2.91M Ended 2025-12-31 |
| 1 year earlier | $3.05M Ended 2025-06-30 | $3.28M Ended 2024-12-31 | $3.29M Ended 2024-12-31 | $3.53M Ended 2024-12-31 |
| 2 years earlier | $3.11M Ended 2024-06-30 | $2.93M Ended 2023-12-31 | $3.23M Ended 2023-12-31 | n/a |
| 3 years earlier | $1.26M Ended 2023-06-30 | $691.0K Ended 2022-12-31 | $3.08M Ended 2022-12-31 | n/a |
| 4 years earlier | $437.1K Ended 2022-06-30 | $160.0K Ended 2021-12-31 | $4.14M Ended 2021-12-31 | n/a |